Voloridge Investment Management
AVEO

Voloridge Investment Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Voloridge Investment Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40,557
Closed -$606K – 1697
2022
Q4 		$606K Buy
+40,557
New +$562K ﹤0.01% 1241

Voloridge Investment Management's AVEO Position: Q1 2023 in Review

Voloridge Investment Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 40,557 shares — an estimated $606K sold.

Voloridge Investment Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $606K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Voloridge Investment Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 40,557 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $606K.
  • Voloridge Investment Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Voloridge Investment Management's AVEO Pharmaceuticals, Inc. position peaked at $606K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.